V8 Peptides — Engineered Performance
Research Library
Nootropic Peptides: Semax and Selank Evidence Map
SelankPreclinical

Nootropic Peptides: Semax and Selank Evidence Map

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What are nootropic peptides in research terms? A consumer label with no shared pathway. The literature for Semax (ACTH-fragment analog) and Selank (tuftsin analog) consists of narrower questions: hippocampal BDNF/trkB expression in rats, GABA-related gene-panel changes in rat cortex, enzymatic and cytokine assays. Findings come from few laboratories and mostly rodent gene-expression work. Name the pathway, not the category. Use the calculator for volumes and check lots on the COA page. For laboratory research use only.

"Nootropic peptides" is a consumer label, and it is a poor guide to what a laboratory can actually test. The research literature behind the label is made of specific, narrower questions: does a short peptide change the expression of a neurotrophin gene in a rat hippocampus, does it shift the transcription of GABA-related genes in cortex, does it alter enzymatic breakdown of an endogenous opioid peptide? This article maps that literature for a researcher who wants to know which questions have been asked of two heptapeptides, Semax and Selank, which readouts those questions rely on, and what the evidence cannot say. It makes no claim about cognition, mood or any use outside the laboratory.

Where the word comes from, and why it does not help

"Nootropic" was coined to describe agents proposed to improve learning and memory without other pharmacological effects. As a laboratory category it is nearly empty: there is no receptor, pathway or assay that all "nootropics" share. The compounds that carry the label are chemically unrelated, and the same peptide may appear in a neuroprotection paper, an anxiety-behavior paper and a gene-expression paper with no common endpoint. Even within the Russian literature that produced Semax and Selank, one paper has examined whether the effects of Selank, Semax and a third peptide lean toward cognitive or anxiolytic behavior depending on experimental conditions (Vasileva et al., 2020). The practical rule for designing an experiment is to drop the label and name the pathway.

Neuropeptides in general are a legitimate and well-studied category. A comprehensive overview emphasizes their multitude and wide distribution in both the peripheral and central nervous system, that receptor subtypes and antagonists provide an experimental framework for their functional roles, and that expression is plastic (Hökfelt et al., 2000). That is the right frame for a short synthetic peptide derived from a natural one: a tool for studying a neuropeptide system, not a "booster".

Two peptides, two parent molecules

According to the V8 product pages, both compounds are synthetic heptapeptides whose first four residues reproduce a natural fragment and whose C-terminal Pro-Gly-Pro tail was added to slow enzymatic degradation. Both originated at the Institute of Molecular Genetics of the Russian Academy of Sciences.

FeatureSemaxSelank
SequenceMet-Glu-His-Phe-Pro-Gly-ProThr-Lys-Pro-Arg-Pro-Gly-Pro
Parent fragmentACTH(4-7)Tuftsin (from the IgG heavy chain)
Molecular formula (product page)C37H51N9O10SC33H57N11O9
Approximate molar mass from formula813.9 g/mol751.9 g/mol
Vial size listed15 mg10 mg
Research applications listedBDNF/NGF expression, neuronal-signaling modelsGABAergic signaling, anxiolytic behavior models, immunomodulation
Library overviewSemax research overviewSelank research overview

The product pages are Semax and Selank, each supplied as lyophilized powder at ≥98% HPLC purity with the storage line of 2–8 °C, or −20 °C for long-term holding, protected from heat, moisture and light. Short, proline-rich peptides like these are small enough to dissolve readily but remain subject to oxidation (the methionine in Semax is a candidate) and adsorption at low concentrations.

What has been measured with Semax

A frequently cited paper examined an ACTH(4-10) analog with a Pro-Gly-Pro extension in the rat. The authors reported that a single application at 50 µg/kg body weight gave a maximal 1.4-fold increase in BDNF protein in the hippocampus, a 1.6-fold increase in trkB tyrosine phosphorylation, and 3-fold and 2-fold increases in exon III BDNF and trkB mRNA, and that exposed animals showed an increase in conditioned avoidance reactions; the authors suggested that the peptide affects hippocampal BDNF/trkB signaling (Dolotov et al., 2006). The experimental ingredients are worth noting: an in-vivo rat model, a defined tissue, protein and mRNA readouts at defined times, and a behavioral task, so the finding is a gene-and-protein level observation in one species, one laboratory and one exposure paradigm. Replicating it would need the same tissue handling, the same time points and an independent group.

Product-page language says published Semax work has also covered transcriptomic studies in experimental ischemia models and structure-activity work on ACTH-fragment analogs; the library has what is Semax and a comparison with the acetylated, amidated version in N-acetyl Semax amidate vs Semax.

What has been measured with Selank

A 2016 study in the journal Frontiers in Pharmacology asked whether Selank, which the authors noted shows a spectrum of effects similar to classical benzodiazepines in earlier studies, might act on GABAergic mechanisms. They analyzed 84 genes involved in neurotransmission in rat frontal cortex 1 and 3 hours after administration of Selank or GABA at 300 µg/kg using real-time PCR, and reported significant changes in expression of a number of genes (Volkova et al., 2016). That is a candidate-pathway approach: a panel of genes chosen in advance, in one brain region, at two early time points. It can generate hypotheses about the GABAergic system, and it cannot show that receptor function changed, because transcripts do not equal protein or activity.

The product page lists three further lines of work: interaction with enkephalin-degrading enzymes, cytokine expression in immune cells, and anxiolytic behavior models. Each has its own readout, and the library goes deeper in what is Selank and Selank vs Semax.

A map of readouts

QuestionSystemReadoutMain limitation
Does the peptide change neurotrophin expression?Rodent tissue or neuronal culturesBDNF/NGF and trkB mRNA by qPCR; protein by immunoassay; receptor phosphorylationSingle time points miss the kinetics; tissue region matters
Does it change GABA-related gene expression?Rat cortex or cultured neuronsGene-panel qPCR; receptor-subunit transcriptsTranscript change is not receptor function
Does it alter enkephalin breakdown?Enzyme assay with purified or tissue enzymeSubstrate cleavage by HPLC or fluorescenceEnzyme source and substrate concentration shape the answer
Does it change cytokine expression?Immune-cell culturesCytokine panels, qPCREndotoxin in reagents can alone drive cytokine responses
Does it change behavior?Rodent anxiety or learning tasksElevated plus maze, avoidance tasksHigh variance; strain, sex and handling effects are large
Is the vial what the label says?Receiving inspectionHPLC trace, mass confirmationChromatographic purity is not net peptide content

Two of those limitations deserve emphasis. Endotoxin contamination in a peptide stock can look like a pro-inflammatory effect, so an immune-cell experiment needs a vehicle control prepared in the same diluent and ideally a low-endotoxin water source. And rodent behavior depends on handling, time of day, housing and the experimenter, so a behavioral conclusion needs blinding and enough animals for the variance, with the sample size set before the experiment begins.

Designing a clean experiment with a short peptide

  1. Name the pathway first. Choose the hypothesis (BDNF/trkB, GABAergic transcription, enzymatic breakdown) and the system that can test it.
  2. Define the time course. Gene expression changes within hours and protein changes follow, so sample at several points.
  3. Use the right controls. Vehicle prepared identically; a scrambled-sequence peptide; and, where a receptor is hypothesized, a selective antagonist.
  4. Measure the stock. Concentration equals mass divided by diluent volume; molar concentration divides that by the molar mass (about 813.9 g/mol for Semax and 751.9 g/mol for Selank from the listed formulas). The reconstitution calculator performs the conversion for any volume, so no per-vial tables are repeated here.
  5. Verify the material. Read the lot document on the COA page and keep the lot number with the data.
  6. Pre-register the analysis. State the primary end point and the statistical test before looking at the data.

Other peptides that appear in the same searches

People who search "nootropic peptides" also meet DSIP, epithalon and thymosin alpha-1, which are separate research tools with separate literatures. The library covers them in what is DSIP, what is epithalon and what is thymosin alpha-1. They share only the fact that they are short peptides, so the same advice applies: name the question, not the category. The general background on peptide handling is in what are research peptides, and the compounds are in the research shop.

What the evidence cannot yet say

  • Most of the cited work comes from a small number of laboratories, so independent replication is thin.
  • Gene-expression findings in one brain region at early time points do not establish a mechanism, and they do not say anything about function.
  • Rodent behavioral findings depend on strain, sex, handling and test conditions, and they do not map onto other species.
  • No result described on this page should be read as a statement about any effect outside a laboratory model.

Frequently asked questions

What does 'nootropic' mean in peptide research?

It is a consumer label with no shared receptor or assay. Research papers ask narrower questions, such as neurotrophin gene expression or GABA-related transcription, and those are the questions to design around.

What are Semax and Selank?

Synthetic heptapeptides. Semax is Met-Glu-His-Phe-Pro-Gly-Pro, an ACTH(4-7)-based analog, and Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, built on tuftsin. Both carry a Pro-Gly-Pro tail added to slow enzymatic degradation.

What did the 2006 Semax paper measure?

In rat hippocampus, BDNF and trkB protein, receptor phosphorylation and mRNA, plus a conditioned avoidance task. The authors suggested modulation of the BDNF/trkB system.

What did the 2016 Selank paper measure?

Expression of 84 neurotransmission-related genes in rat frontal cortex 1 and 3 hours after Selank or GABA administration, using real-time PCR.

Does gene expression change prove a receptor mechanism?

No. Transcript levels do not equal protein levels or receptor function, so follow-up with protein and functional assays is needed.

Why can endotoxin affect immune-cell experiments?

Endotoxin alone can trigger cytokine responses, so a vehicle control prepared in the same diluent is essential.

What molar masses apply?

About 813.9 g/mol for Semax (C37H51N9O10S) and 751.9 g/mol for Selank (C33H57N11O9), computed from the formulas on the product pages.

How are Semax and Selank stored?

The product pages state refrigerate at 2–8 °C, −20 °C for long-term holding, and protect from heat, moisture and light.

Are there ready-made concentration tables here?

No. The page gives the formula, mass divided by volume, and points to the reconstitution calculator so figures come from the actual vial and chosen volume.

Which other peptides are searched alongside these?

DSIP, epithalon and thymosin alpha-1 appear in similar searches but are separate research tools with their own literatures.

Research-use statement

Everything on this page is educational background for laboratory research use only. V8 Peptides products are sold as research materials, not for human or animal consumption, and nothing here describes a use outside the laboratory. Browse the research catalog, check lot documents on the COA page, or run volumes through the reconstitution calculator.

Related reading: Selank in Animal Models: Preclinical Findings Reviewed, Selank Quality Control: Purity and Identity Checks, Selank Anxiolytic Peptide Research: Models and Readouts.

References

  1. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60. doi:10.1016/j.brainres.2006.07.108
  2. Volkova A, Shadrina M, Kolomin T, et al. Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Front Pharmacol. 2016;7:31. doi:10.3389/fphar.2016.00031
  3. Hökfelt T, Broberger C, Xu ZQ, Sergeyev V, Ubink R, Diez M. Neuropeptides: an overview. Neuropharmacology. 2000;39(8):1337-1356. doi:10.1016/S0028-3908(00)00010-1
  4. Vasileva LV, Saitgareeva AR, Bugaeva LN, Gorbunov AA, Lebedev AA. Predominance of nootropic or anxiolytic effects of Selank, Semax, and Noopept peptides depending on the experimental conditions. Neurochem J. 2020;14:292-296. doi:10.1134/S1819712420030113

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.